XML 99 R84.htm IDEA: XBRL DOCUMENT v3.21.2
Segment Information (Schedule of Business Segments) (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Segment Reporting Information [Line Items]          
Net sales $ 2,198 $ 1,193 $ 3,996 $ 2,653  
Other (charges) gains, net (Note 14) (3) (21) 3 (27)  
Operating profit (loss) 567 83 893 277  
Equity in net earnings (loss) of affiliates 37 31 66 88  
Depreciation and amortization 91 87 181 172  
Capital expenditures 113 [1] 80 [1] 186 [2] 166 [2]  
Goodwill and intangible assets, net 1,447   1,447   $ 1,485
Total assets 11,220   11,220   10,909
Increase (decrease) in accrued capital expenditures 3 (8) (16) (41)  
Acetate Tow          
Segment Reporting Information [Line Items]          
Net sales 138 127 257 256  
Acetyl Chain          
Segment Reporting Information [Line Items]          
Net sales [3] 1,378 646 2,412 1,414  
Engineered Materials          
Segment Reporting Information [Line Items]          
Net sales 682 420 1,327 983  
Operating Segments [Member] | Acetate Tow          
Segment Reporting Information [Line Items]          
Net sales 138 127 257 256  
Other (charges) gains, net (Note 14) 0 0 0 (1)  
Operating profit (loss) 24 31 40 58  
Equity in net earnings (loss) of affiliates 0 0 0 0  
Depreciation and amortization 9 9 19 17  
Capital expenditures 10 6 21 16  
Goodwill and intangible assets, net 154   154   154
Total assets 1,057   1,057   975
Operating Segments [Member] | Acetyl Chain          
Segment Reporting Information [Line Items]          
Net sales 1,409 662 2,465 1,461  
Other (charges) gains, net (Note 14) 0 5 0 5  
Operating profit (loss) 516 121 767 256  
Equity in net earnings (loss) of affiliates 2 0 4 1  
Depreciation and amortization 43 42 84 81  
Capital expenditures 65 38 98 81  
Goodwill and intangible assets, net 291   291   301
Total assets 4,461   4,461   3,930
Operating Segments [Member] | Engineered Materials          
Segment Reporting Information [Line Items]          
Net sales 682 420 1,327 983  
Other (charges) gains, net (Note 14) (1) (25) 6 (25)  
Operating profit (loss) 123 (13) 253 89  
Equity in net earnings (loss) of affiliates 32 26 57 79  
Depreciation and amortization 35 32 70 66  
Capital expenditures 33 28 56 52  
Goodwill and intangible assets, net 1,002   1,002   1,030
Total assets 4,138   4,138   3,990
Corporate, Non-Segment [Member] | Other          
Segment Reporting Information [Line Items]          
Net sales 0 0 0 0  
Other (charges) gains, net (Note 14) (2) (1) (3) (6)  
Operating profit (loss) (96) (56) (167) (126)  
Equity in net earnings (loss) of affiliates 3 5 5 8  
Depreciation and amortization 4 4 8 8  
Capital expenditures 5 8 11 17  
Goodwill and intangible assets, net 0   0   0
Total assets 1,564   1,564   2,014
Eliminations [Member]          
Segment Reporting Information [Line Items]          
Net sales (31) [4] (16) [4] (53) [5] (47) [5]  
Other (charges) gains, net (Note 14) 0 0 0 0  
Operating profit (loss) 0 0 0 0  
Equity in net earnings (loss) of affiliates 0 0 0 0  
Depreciation and amortization 0 0 0 0  
Capital expenditures 0 0 0 0  
Goodwill and intangible assets, net 0   0   0
Total assets 0   0   $ 0
Eliminations [Member] | Acetyl Chain          
Segment Reporting Information [Line Items]          
Net sales $ 31 $ 16 $ 53 $ 47  
[1] Includes an increase in accrued capital expenditures of $3 million and a decrease of $8 million for the three months ended June 30, 2021 and 2020, respectively.
[2] Includes a decrease in accrued capital expenditures of $16 million and $41 million for the six months ended June 30, 2021 and 2020, respectively.
[3] Excludes intersegment sales of $31 million and $16 million for the three months ended June 30, 2021 and 2020, respectively. Excludes intersegment sales of $53 million and $47 million for the six months ended June 30, 2021 and 2020, respectively.
[4] Includes intersegment sales primarily related to the Acetyl Chain.
[5] Includes intersegment sales primarily related to the Acetyl Chain.